Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC9H11NO4 |
InChIKeyJRBXPUUAYKCCLQ-QMMMGPOBSA-N |
CAS Registry71522-58-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 3 | - | - | |
Neoplasms | Phase 3 | - | - |